Home › Markets › Industrials › SOLS

Solstice Advanced Materials Inc. Common Stock (SOLS)

SOLS trades on Nasdaq in Industrials, Major Chemicals. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$60.91
+0.33% on the day
Market cap
$9.7B
Mid cap
Revenue · 2025
$3.9B
+3.1% on 2024
Net income · 2025
$237.0M
6.1% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerSOLS on Nasdaq
SectorIndustrials
IndustryMajor Chemicals
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0002064953
SEC industry codeChemicals & Allied Products
Incorporated inDE

Financials · 2025

LineValue
Revenue$3.9B
Net income$237.0M
Operating incomeNot in SEC XBRL data
Net margin6.1%
Operating marginOperating income not reported
Revenue growth+3.1%
Cash$534.0M
Total assets$5.7B
P/E (computed)40.8×
P/S (computed)2.5×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentDRS2025-05-01
Latest annual report10-K2026-02-19
Latest quarterly / interim10-Q2026-07-30
Latest current report
FORM 8-K
8-K2026-08-27
Latest proxyDEFA14A2026-05-18

Source: SEC EDGAR submissions feed, 175 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-0.7%
1 month+4.8%
3 months+2.9%
Year to date+23.3%
1 yearNot enough price history
From 52-week high-32.4%

Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Major Chemicals

TickerCompanyPriceDayMarket cap
ESIElement Solutions Inc.$37.20+2.06%$9.1B
NEUNewMarket Corp$898.98+0.29%$8.3B
ALBAlbemarle Corporation$97.65-0.87%$11.5B
WLKWestlake Corporation$61.86+0.02%$7.9B
EMNEastman Chemical Company$63.00+1.45%$7.2B
HXLHexcel Corporation$86.13+1.39%$6.5B
SXTSensient Technologies Corporation$132.55+1.97%$5.6B
BCPCBalchem Corporation$169.72+0.91%$5.4B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier